Complete report $8,500. DataPack (test volumes, sales forecasts, supplier shares) $5,500.
This new 320-page report from Venture Planning Group contains 83 tables and provides analysis of the global tumor markers and special chemistry testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.
The report provides test volume and sales forecasts by country and market segment for the following assays:
AFP
CA 15-3/27-29
CA 19-9
CEA
Follate (Folic Acid)
Glycosylated Hemoglobin
HCG
25-Hydroxy Vitamin D2 and D3
Occult Blood
PAP
PSA
Thyroglobulin
Vitamin B-12
During the next decade, the tumor markers and special chemistry testing market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.
World Tumor Markers and Special Chemistry Testing Market 2014: US, Europe (France, Germany, Italy, Spain, UK), Japan is a unique worldwide market and technology assessment designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study provides five-year forecasts for major assays; compares features of leading analyzers; and profiles key competitors.
Contains 320 pages and 83 tables